Literature DB >> 6703985

Progression of pseudovitelliform macular dystrophy.

B L Hodes, L A Feiner, S H Sherman, D Cunningham.   

Abstract

Pseudovitelliform macular dystrophy is a dominantly inherited macular disorder. It is characterized by the presence of horizontally oval yellowish deposits within the maculas that are approximately one-third disc diameter in size. As classically described, progression of the lesions over a follow-up period of as long as six years has not been described and the prognosis for retention of good visual function is excellent. We report the ophthalmoscopic appearance of six eyes of three patients from a very subtle alteration of macular pigmentation to severe disruption of macular architecture, and demonstrate in one of our patients drastic deterioration in both ophthalmoscopic appearance and visual function over a three-year period of follow-up. The prognosis for retention of good vision in this disorder must include the possibility of the eventual development of severe visual impairment.

Entities:  

Mesh:

Year:  1984        PMID: 6703985     DOI: 10.1001/archopht.1984.01040030299023

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  [Visual loss after pars plana vitrectomy with membrane peeling].

Authors:  M Schmidt; N Schrage; C Clemens; N Eter
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

2.  Multimodal imaging of adult-onset foveomacular vitelliform dystrophy.

Authors:  Seanna Grob; Yoshihiro Yonekawa; Dean Eliott
Journal:  Saudi J Ophthalmol       Date:  2014-04

3.  [Clinical diagnostic prerequisites for adult vitelliform macular dystrophy].

Authors:  A B Renner; H Tillack; H Kraus; U Kellner; M H Foerster
Journal:  Ophthalmologe       Date:  2004-09       Impact factor: 1.059

4.  Adult-Onset Vitelliform Macular Dystrophy caused by BEST1 p.Ile38Ser Mutation is a Mild Form of Best Vitelliform Macular Dystrophy.

Authors:  Ikhyun Jun; Joon Suk Lee; Ji Hwan Lee; Christopher Seungkyu Lee; Seung-Il Choi; Heon Yung Gee; Min Goo Lee; Eung Kweon Kim
Journal:  Sci Rep       Date:  2017-08-22       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.